Enzalutamide in Castration-Resistant Prostate Cancer

Giacomo Bregni, Sara E Rebuzzi, Giuseppe Fornarini

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1380-1
Number of pages2
JournalNew England Journal of Medicine
Volume379
Issue number14
DOIs
Publication statusPublished - Oct 4 2018

Keywords

  • Antineoplastic Agents
  • Disease-Free Survival
  • Humans
  • Male
  • Phenylthiohydantoin/analogs & derivatives
  • Prostatic Neoplasms, Castration-Resistant
  • Receptors, Androgen
  • Treatment Outcome

Cite this

Enzalutamide in Castration-Resistant Prostate Cancer. / Bregni, Giacomo; Rebuzzi, Sara E; Fornarini, Giuseppe.

In: New England Journal of Medicine, Vol. 379, No. 14, 04.10.2018, p. 1380-1.

Research output: Contribution to journalArticle

Bregni, Giacomo ; Rebuzzi, Sara E ; Fornarini, Giuseppe. / Enzalutamide in Castration-Resistant Prostate Cancer. In: New England Journal of Medicine. 2018 ; Vol. 379, No. 14. pp. 1380-1.
@article{eb44a08cdf5b4e0eab7b25c70d70cdb4,
title = "Enzalutamide in Castration-Resistant Prostate Cancer",
keywords = "Antineoplastic Agents, Disease-Free Survival, Humans, Male, Phenylthiohydantoin/analogs & derivatives, Prostatic Neoplasms, Castration-Resistant, Receptors, Androgen, Treatment Outcome",
author = "Giacomo Bregni and Rebuzzi, {Sara E} and Giuseppe Fornarini",
year = "2018",
month = "10",
day = "4",
doi = "10.1056/NEJMc1810065",
language = "English",
volume = "379",
pages = "1380--1",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "14",

}

TY - JOUR

T1 - Enzalutamide in Castration-Resistant Prostate Cancer

AU - Bregni, Giacomo

AU - Rebuzzi, Sara E

AU - Fornarini, Giuseppe

PY - 2018/10/4

Y1 - 2018/10/4

KW - Antineoplastic Agents

KW - Disease-Free Survival

KW - Humans

KW - Male

KW - Phenylthiohydantoin/analogs & derivatives

KW - Prostatic Neoplasms, Castration-Resistant

KW - Receptors, Androgen

KW - Treatment Outcome

U2 - 10.1056/NEJMc1810065

DO - 10.1056/NEJMc1810065

M3 - Article

C2 - 30284801

VL - 379

SP - 1380

EP - 1381

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 14

ER -